Translate Bio’s plans to put a second messenger RNA drug in the clinic in the first half of 2019 has just ground to a halt in front of a sudden regulatory red light.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,